Switching off HER-2/neu in a tetracycline-controlled mouse tumor model leads to apoptosis and tumor-size-dependent remission.
Schiffer, Ilka B
Switching off HER-2/neu in a tetracycline-controlled mouse tumor model leads to apoptosis and tumor-size-dependent remission. [electronic resource] - Cancer research Nov 2003 - 7221-31 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0008-5472
Animals
Apoptosis--physiology
Cell Cycle--physiology
Cell Division--physiology
Down-Regulation
Gene Expression Regulation, Neoplastic
Humans
Male
Mice
Mice, Nude
NIH 3T3 Cells
Neoplasms, Experimental--genetics
Promoter Regions, Genetic
Receptor, ErbB-2--antagonists & inhibitors
Tetracycline--pharmacology
Tetracyclines--pharmacology
Switching off HER-2/neu in a tetracycline-controlled mouse tumor model leads to apoptosis and tumor-size-dependent remission. [electronic resource] - Cancer research Nov 2003 - 7221-31 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0008-5472
Animals
Apoptosis--physiology
Cell Cycle--physiology
Cell Division--physiology
Down-Regulation
Gene Expression Regulation, Neoplastic
Humans
Male
Mice
Mice, Nude
NIH 3T3 Cells
Neoplasms, Experimental--genetics
Promoter Regions, Genetic
Receptor, ErbB-2--antagonists & inhibitors
Tetracycline--pharmacology
Tetracyclines--pharmacology